TScan Therapeutics, Inc. (TCRX) NASDAQ

2.47

+0.035(+1.44%)

Updated at February 05 02:10PM

Currency In USD

Valuation

Market Cap382.45M
Enterprise Value341.52M
P/E Ratio-2.59
PEG Ratio2.72
Price/Sales Ratio13.85
Price/Book Ratio1.26
Enterprise/Revenue9.29
Enterprise/EBITDA-0.84

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterSeptember 30, 2024

Profitability

Profit Margin-11.89
Operating Margin-12.76

Management Effectiveness

Return On Assets-0.32
Return On Equity-0.59

Income Statement

Revenue21.05M
Revenue/Share0.08
Gross Profit-67.1M
EBITDA-80.1M
Net Income-89.22M
Diluted EPS-1.36

Balance Sheet

Total Cash271.12M
Total Cash/Share2.28
Total Debt90.36M
Total Debt/Equity0.39
Current Ratio9.56
Book Value Per Share1.93

Price History

52-Week Change-56.22
52-Week High9.69
52-Week Low2.31
Moving Average 50 Days3.26
Moving Average 200 Days5.7

Statistics

Average Volume427,870
Shares Outstanding53.37M
% Held by Institutions35.24

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A